Literature DB >> 21215419

Can Awaji ALS criteria provide earlier diagnosis than the revised El Escorial criteria?

Takahiro Okita1, Hiroyuki Nodera, Yoshiko Shibuta, Atsuko Nodera, Kotaro Asanuma, Yoshimitsu Shimatani, Kenta Sato, Yuishin Izumi, Ryuji Kaji.   

Abstract

BACKGROUND: Recently, new electrophysiological ALS criteria incorporating fasciculation potentials (FPs) as evidence for lower motor neuron signs (Awaji Criteria (AC)) was proposed to provide earlier detection of early-stage ALS than revised El Escorial electrophysiological criteria (REEC). However, serial electrophysiological analysis is lacking to ascertain the original intention. The objective for this study was to elucidate whether electrophysiological criteria set for AC detects ALS earlier than REEC's counterpart in patients with ALS.
METHODS: Of the 51 patients who were clinically suspected of ALS, 35 patients prospectively received serial electrophysiological studies every 3 months until (1) both electrophysiological AC and REEC criteria were met in more than two muscles representing both of the cervical and lumbosacral segments or (2) either clinically definite or clinically probable REEC criteria was met. The intervals were determined between the initial disease onset and when the respective electrophysiological criteria were met.
RESULTS: Electrophysiological diagnostic criteria were met in 94.3% by AC and 40% by REEC at the initial visits. The intervals between the disease onset and the time of meeting the electrophysiological criteria were shorter in AC (mean: 9.0 months) than in REEC (mean: 15.2 months) (P<0.01). Eleven patients who met only AC electrophysiological criteria on the initial study subsequently met REEC electrophysiological criteria with the mean interval of 3.8 months. A higher percentage of bulbar-type ALS (83.3%) met AC than limb-onset ALS (43.4%) (P<0.05). FPs tended to be more frequently observed than fib/psw in the muscles outside the region of initial clinical onset.
CONCLUSION: Electrophysiological criteria of AC were met earlier than that of REEC in ALS patients, especially in patients with bulbar onset. Early recognition of ALS by AC may allow effective therapeutic intervention in the early disease stage.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21215419     DOI: 10.1016/j.jns.2010.12.007

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Prognostic Factors in Amyotrophic Lateral Sclerosis: A Population-Based Study.

Authors:  Mirian Conceicao Moura; Maria Rita Carvalho Garbi Novaes; Emanoel Junio Eduardo; Yuri S S P Zago; Ricardo Del Negro Barroso Freitas; Luiz Augusto Casulari
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

2.  Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study.

Authors:  Ryuji Kaji; Takashi Imai; Yasuo Iwasaki; Koichi Okamoto; Masanori Nakagawa; Yasuo Ohashi; Takao Takase; Takahisa Hanada; Hiroki Shimizu; Kunio Tashiro; Shigeki Kuzuhara
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-01-13       Impact factor: 10.154

Review 3.  ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease.

Authors:  Elizabeth B Moloney; Fred de Winter; Joost Verhaagen
Journal:  Front Neurosci       Date:  2014-08-14       Impact factor: 4.677

4.  The Gold Coast criteria increases the diagnostic sensitivity for amyotrophic lateral sclerosis in a Chinese population.

Authors:  Dongchao Shen; Xunzhe Yang; Yanying Wang; Di He; Xiaohan Sun; Zhengyi Cai; Jinyue Li; Mingsheng Liu; Liying Cui
Journal:  Transl Neurodegener       Date:  2021-08-09       Impact factor: 8.014

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.